See every side of every news story
Published loading...Updated

Datar Cancer Genetics Unveils Advanced Blood Test for MRD

Summary by Clinical Lab Products
Summary: Datar Cancer Genetics introduced a highly sensitive blood test that combines tumor-agnostic NGS and tumor-informed dd-PCR to detect MRD and enable early intervention in solid organ cancers. Takeaways: Early Cancer Recurrence Detection: Target-MRD identifies molecular residual disease (MRD) at the molecular level, allowing oncologists to intervene before cancer relapse becomes clinically detectable. Dual-Technology Approach: The test co…
DisclaimerThis story is only covered by news sources that have yet to be evaluated by the independent media monitoring agencies we use to assess the quality and reliability of news outlets on our platform. Learn more here.

1 Articles

All
Left
Center
Right
Think freely.Subscribe and get full access to Ground NewsSubscriptions start at $9.99/yearSubscribe

Bias Distribution

  • There is no tracked Bias information for the sources covering this story.
Factuality

To view factuality data please Upgrade to Premium

Ownership

To view ownership data please Upgrade to Vantage

Clinical Lab Products broke the news in on Thursday, January 30, 2025.
Sources are mostly out of (0)